BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 46 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $326,000 | -99.0% | 7,563 | -98.9% | 0.00% | -100.0% |
Q4 2020 | $31,646,000 | +22.8% | 684,989 | +15.3% | 0.04% | +6.1% |
Q3 2020 | $25,768,000 | +7638.1% | 594,294 | +9357.3% | 0.03% | – |
Q2 2020 | $333,000 | +296.4% | 6,284 | +67.7% | 0.00% | – |
Q1 2020 | $84,000 | +1300.0% | 3,748 | +358.2% | 0.00% | – |
Q3 2019 | $6,000 | – | 818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |